filmov
tv
ESC 21: FIGARO-DKD
Показать описание
Highlights do ESC 21: vamos falar sobre firenenona e o estudo FIGARO-DKD?
CardioEssentials e inoVMJsaude
Рекомендации по теме
0:01:31
ESC 21: FIGARO-DKD
0:03:59
ESC TV at #ESCCongress 2021 - FIGARO-DKD
0:07:20
La SEC te lleva a ESC21 [IN] ∙ FIGARO-DKD Trial
0:04:44
FIGARO-DKD Trial Results
0:05:45
ESC 2022: FIDELITY: Finerenone in Pts With Chronic Kidney Disease | Prof Gerasimos Filippatos
0:14:25
Insights from the FIGARO-DKD and FIDELIO-DKD trials - English Language - Dr. Gawad
0:25:19
View from the Thoraxcenter: ESC 21 Late-breaking Science Preview
0:26:55
Dr. Rajeev Agrawal - Insights from the FIDELIO-DKD and FIGARO-DKD Trial
1:18:46
best of ESC 2021 Wave 2
0:17:59
Dr. Per-Hernik Groop - New Ways to Understand Kidney Disease in Diabetes
0:05:00
La SEC te lleva a HF21 [IN] ∙ FIDELIO-DKD Trial
0:01:33
EMPEROR Preserved: Empagliflozin in heart failure with preserved ejection fraction
0:03:21
FIDELIO DKD Results
0:03:42
ESC TV at #ESCCongress 2021 - FIDELITY Analysis
0:07:19
La SEC te lleva a ESC21 [IN] ∙ EMPEROR-Pooled
0:34:04
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
0:06:06
La SEC te lleva a ESC21 [IN] ∙ ACST-2: stenting vs surgery for tight carotid stenosis
0:07:32
Day 2 Highlights | ESC Congress 2021
0:04:48
La SEC te lleva a ESC21 [IN] ∙ RIPCORD 2 Trial
0:05:32
La SEC te lleva a ESC21 [IN] ∙ LOOP Study
0:01:54
Effect of Finerenone on Chronic Kidney Disease Outcomes in T
0:09:42
EMPEROR Preserved | EMPEROR Pooled Trial Results
0:06:18
La SEC te lleva a ESC21 [IN] ∙ AVANTI: Dual VP-receptor Antagonism in HF
0:53:59
Finerenone e CKD: FIDELIO-DKD Trial
0:01:31
0:03:59
0:07:20
0:04:44
0:05:45
0:14:25
0:25:19
0:26:55
1:18:46
0:17:59
0:05:00
0:01:33
0:03:21
0:03:42
0:07:19
0:34:04
0:06:06
0:07:32
0:04:48
0:05:32
0:01:54
0:09:42
0:06:18
0:53:59